Cloning and characterization of the highly expressed ETEA gene from blood cells of atopic dermatitis patients

Biochemical and Biophysical Research Communications

Volumn 297, Issue 5, 2002, Pages 1282-1290

  Imai, Yukiho ^a   Nakada, Akiko ^a   Hashida, Ryoichi ^a   Sugita, Yuji ^a   Tanaka, Toshio ^b   Tsujimoto, Gozoh ^c   Matsumoto, Kenji ^c   Akasawa, Akira ^c   Saito, Hirohisa ^c   Oshida, Tadahilo ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Atopic dermatitis; Eosinophils; ETEA; Expression; FAF1; Fas; T cells; Transcription

Indexed keywords

CD3 ANTIGEN; CELL PROTEIN; COMPLEMENTARY DNA; FAS ANTIGEN; FAS ASSOCIATED FACTOR 1; HYBRID PROTEIN; PROTEIN EGFP; PROTEIN ETEA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; BLOOD CELL; CONTROLLED STUDY; CYTOPLASM; EOSINOPHIL; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; T LYMPHOCYTE; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM;

AMINO ACID SEQUENCE; APOPTOSIS; BLOOD PROTEINS; BLOTTING, NORTHERN; CELL DEATH; CELL LINE; CLONING, MOLECULAR; CYTOPLASM; DERMATITIS, ATOPIC; DNA, COMPLEMENTARY; EOSINOPHILS; GENE EXPRESSION PROFILING; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 18644364547     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02380-X     Document Type: Article

References (25)

1. P. Parronchi, D. Macchia, M.P. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A.A. Ansari, S. Romagnani, Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production, Proc. Natl. Acad. Sci. USA 88 (1991) 4538-4542.
2. E.A. Wierenga, M. Snoek, C. de Groot, I. Chretien, J.D. Bos, H.M. Jansen, M.L. Kapsenberg, Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients, J. Immunol. 144 (1990) 4651-4656.
3. M. Grewe, C.A. Bruijnzeel-Koomen, E. Schopf, T. Thepen, A.G. Langeveld-Wildschut, T. Ruzicka, J. Krutmann, A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis, Immunol. Today 19 (1998) 359-361.
4. M.K. Kagi, B. Wuthrich, E. Montano, J. Barandun, K. Blaser, C. Walker, Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals, Int. Arch. Allergy Immunol. 103 (1994) 332-340.
5. A. Kapp, The role of eosinophils in the pathogenesis of atopic dermatitis-eosinophil granule proteins as markers of disease activity, Allergy 48 (1993) 1-5.
6. L.B. Martin, H. Kita, K.M. Leiferman, G.J. Gleich, Eosinophils in allergy: role in disease, degranulation, and cytokines, Int. Arch. Allergy Immunol. 109 (1996) 207-215.
7. G.J. Gleich, Mechanisms of eosinophil-associated inflammation, J. Allergy Clin. Immunol. 105 (2000) 651-663.
8. S.W. Ryu, S.K. Chae, K.J. Lee, E. Kim, Identification and characterization of human Fas-associated factor 1, hFAF1, Biochem. Biophys. Res. Commun. 262 (1999) 388-394.
9. T. Nagase, K. Ishikawa, M. Suyama, R. Kikuno, M. Hirosawa, N. Miyajima, A. Tanaka, H. Kotani, N. Nomura, O. Ohara, Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro, DNA Res. 5 (1998) 355-364.
10. I. Nomura, K. Tanaka, H. Tomita, T. Katsunuma, Y. Ohya, N. Ikeda, T. Takeda, H. Saito, A. Akasawa, Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis, J. Allergy Clin. Immunol. 104 (1999) 441-446.
11. B. Guerra, B. Boldyreff, O.G. Issinger, FAS-associated factor 1 interacts with protein kinase CK2 in vivo upon apoptosis induction, Int. J. Oncol. 19 (2001) 1117-1126.
12. D. Kabelitz, T. Pohl, K. Pechhold, Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes, Immunol. Today 14 (1993) 338-339.
13. G.H. Fisher, F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middleton, A.Y. Lin, W. Strober, M.J. Lenardo, J.M. Puck, Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome, Cell 81 (1995) 935-946.
14. F. Rieux-Laucat, F. Le Deist, C. Hivroz, I.A. Roberts, K.M. Debatin, A. Fischer, J.P. de Villartay, Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity, Science 268 (1995) 1347-1349.
15. K. Chu, X. Niu, L.T. Williams, A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis, Proc. Natl. Acad. Sci. USA 92 (1995) 11894-11898.
16. S.W. Ryu, E. Kim, Apoptosis induced by human Fas-associated factor 1, hFAF1, requires its ubiquitin homologous domain, but not the Fas-binding domain, Biochem. Biophys. Res. Commun. 286 (2001) 1027-1032.
17. H.H. Jensen, M. Hjerrild, B. Guerra, M.R. Larsen, P. Hojrup, B. Boldyreff, Phosphorylation of the Fas-associated factor FAF1 by protein kinase CK2 and identification of serines 289 and 291 as the in vitro phosphorylation sites, Int. J. Biochem. Cell Biol. 33 (2001) 577-589.
18. S. Jayaraman, M. Castro, M. O'Sullivan, M.J. Bragdon, M.J. Holtzman, Resistance to Fas-mediated T cell apoptosis in asthma, J. Immunol. 162 (1999) 1717-1722.
19. F. Ramsdell, M.S. Seaman, R.E. Miller, K.S. Picha, M.K. Kennedy, D.H. Lynch, Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death, Int. Immunol. 6 (1994) 1545-1553.
20. A.S. Varadhachary, S.N. Perdow, C. Hu, M. Ramanarayanan, P. Salgame, Differential ability of T cell subsets to undergo activation-induced cell death, Proc. Natl. Acad. Sci. USA 94 (1997) 5778-5783.
21. B. Wedi, U. Raap, H. Lewrick, A. Kapp, Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis, J. Allergy Clin. Immunol. 100 (1997) 536-543.
22. D.J. Evans, M.A. Lindsay, B.J. O3Connor, P.J. Barnes, Priming of circulating human eosinophils following late response to allergen challenge, Eur. Respir. J. 9 (1996) 703-708.
23. H. Kankaanranta, M.A. Lindsay, M.A. Giembycz, X. Zhang, E. Moilanen, P.J. Barnes, Delayed eosinophil apoptosis in asthma, J. Allergy Clin. Immunol. 106 (2000) 77-83.
24. K. Matsumoto, R.P. Schleimer, H. Saito, Y. Iikura, B.S. Bochner, Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro, Blood 86 (1995) 1437-1443.
25. H. Hebestreit, B. Dibbert, I. Balatti, D. Braun, A. Schapowal, K. Blaser, H.U. Simon, Disruption of fas receptor signaling by nitric oxide in eosinophils, J. Exp. Med. 187 (1998) 415-425.